![Amy Pott](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy Pott
Directeur/Membre du Conseil chez
EUPRAXIA PHARMACEUTICALS INC.
Fortune : - $ au 31/07/2026
Profil
Amy Pott is Director at Eupraxia Pharmaceuticals, Inc. since 2026 and Chief Global Commercialization Officer at enGene Therapeutics, Inc. since 2025.
Former roles include Director-Business Model Innovation at Baxter Healthcare Corp.
from 2014 to 2015, Independent Director at Wave Life Sciences Ltd. from 2019 to 2021, Group Vice President at Shire Plc from 2016 to 2019, Senior Vice President-Strategic Brand Marketing at Astellas Pharma, Inc., VP-Strategy, Planning & Analytics at Baxalta, Inc. from 2015 to 2016, and President-North America at Swedish Orphan Biovitrum AB. Education includes undergraduate studies at the University of Bristol and graduate studies at the London School of Economics & Political Science.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 | |
| 25/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Amy Pott
| Sociétés | Poste | Début |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Corporate Officer/Principal | 28/05/2025 |
| EUPRAXIA PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 18/06/2026 |
Anciens postes connus de Amy Pott
| Sociétés | Poste | Fin |
|---|---|---|
| WAVE LIFE SCIENCES, INC. | Directeur/Membre du Conseil | 08/01/2021 |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Corporate Officer/Principal | 01/04/2019 |
| BAXALTA INC | Corporate Officer/Principal | 01/01/2016 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Public Communications Contact | 01/01/2009 |
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | - |
Formation de Amy Pott
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
70
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
Eupraxia Pharmaceuticals, Inc.
 Eupraxia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on the development of delivered, extended-release alternatives to currently approved drugs | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Wave Life Sciences Ltd.
 Wave Life Sciences Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA oligonucleotides medicines | Health Technology |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma, Inc.
 Astellas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals and related medical products | Health Technology |
London School of Economics & Political Science
 London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
